Business analyst

EQS-News: MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value

Retrieved on: 
Tuesday, February 6, 2024

Separately, MorphoSys entered into a Purchase Agreement to sell and transfer all rights worldwide related to tafasitamab to Incyte Corporation (“Incyte”).

Key Points: 
  • Separately, MorphoSys entered into a Purchase Agreement to sell and transfer all rights worldwide related to tafasitamab to Incyte Corporation (“Incyte”).
  • “Novartis shares our steadfast commitment to develop and deliver transformative medicines that address the dire needs of cancer patients.
  • Novartis intends to offer MorphoSys’ shareholders € 68.00 per share in cash, for a total equity value of € 2.7 billion.
  • Creates New Opportunities for MorphoSys’ Colleagues: The agreement between Novartis and MorphoSys includes employee commitments.

Energem Corp and Graphjet Technology Sdn. Bhd. Announce Effectiveness of Registration Statement and Date of Energem Corp’s Shareholder Meeting to Approve Proposed Business Combination

Retrieved on: 
Monday, February 5, 2024

Kuala Lumpur, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology Sdn. Bhd., a Malaysian private limited company (“Graphjet”) and Energem Corp (“Energem”) (Nasdaq: ENCP, ENCPW), a publicly-traded special purpose acquisition company, today announced that the Securities and Exchange Commission ("SEC") has declared effective the registration Statement on Form S-4 ("Registration Statement") in connection with Graphjet and Energem’s previously announced proposed business combination (the “Business Combination”). The Registration Statement provides important information about Graphjet, Energem and the Business Combination.

Key Points: 
  • Bhd., a Malaysian private limited company (“Graphjet”) and Energem Corp (“Energem”) (Nasdaq: ENCP, ENCPW), a publicly-traded special purpose acquisition company, today announced that the Securities and Exchange Commission ("SEC") has declared effective the registration Statement on Form S-4 ("Registration Statement") in connection with Graphjet and Energem’s previously announced proposed business combination (the “Business Combination”).
  • The Registration Statement provides important information about Graphjet, Energem and the Business Combination.
  • Energem also announced that it will hold an extraordinary general meeting of its shareholders at the office of Energem at Level 3, Tower 11, Avenue 5, No.
  • The Business Combination is expected to close shortly after the extraordinary general meeting of the shareholders of Energem and Graphjet, subject to the approval of the shareholders of each of Energem and Graphjet at those meetings.

iLearningEngines, Inc. and Arrowroot Acquisition Corp. Announce Effectiveness of Registration Statement and February 12, 2024 Special Meeting to Approve Business Combination

Retrieved on: 
Monday, February 5, 2024

Arrowroot also commenced mailing the definitive proxy statement/prospectus on or about February 2, 2024, which was included in the Registration Statement, relating to the special meeting of stockholders to be held in connection with the Business Combination (the “Special Meeting”).

Key Points: 
  • Arrowroot also commenced mailing the definitive proxy statement/prospectus on or about February 2, 2024, which was included in the Registration Statement, relating to the special meeting of stockholders to be held in connection with the Business Combination (the “Special Meeting”).
  • The Special Meeting is scheduled to be held on February 12, 2024 at 9 a.m. Eastern Time.
  • Holders of Arrowroot’s common stock at the close of business on the record date of January 18, 2024 are entitled to notice of the Special Meeting and to vote at the Special Meeting.
  • More details about the Business Combination and the resolutions to be voted upon at the Special Meeting can be found in the definitive proxy statement/prospectus filed by Arrowroot, available at: http://www.sec.gov .

Chesapeake Granite Wash Trust Announces Distribution of $0.0214 Per Common Unit

Retrieved on: 
Monday, February 5, 2024

Cash held in reserve will be invested as required by the Trust Agreement.

Key Points: 
  • Cash held in reserve will be invested as required by the Trust Agreement.
  • The Trust owns royalty interests in certain oil and natural gas properties in the Colony Granite Wash play in Washita County, Oklahoma.
  • The Trust is entitled to receive proceeds from the sale of production attributable to the royalty interests.
  • For additional information regarding the Trust and its results of operations and financial condition, please refer to the Trust’s SEC filings.

Slam Corp. and Lynk Global, Inc. Announce Definitive Business Combination Agreement

Retrieved on: 
Monday, February 5, 2024

(“Lynk”), the world’s leading satellite-direct-to-standard-phone (“sat2phone”) telecoms provider, and Slam Corp. (NASDAQ: SLAM), a special purpose acquisition company (“Slam”), today announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”) under which Slam will combine with Lynk.

Key Points: 
  • (“Lynk”), the world’s leading satellite-direct-to-standard-phone (“sat2phone”) telecoms provider, and Slam Corp. (NASDAQ: SLAM), a special purpose acquisition company (“Slam”), today announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”) under which Slam will combine with Lynk.
  • Charles Miller added, “Through our proposed business combination with Slam, we believe Lynk will be well-positioned to raise capital through several avenues.
  • Under the terms of the business combination agreement, the transaction values Lynk at a pre-money enterprise value of $800 million.
  • Additional information about the proposed Business Combination will be described in the Registration Statement relating to the proposed Business Combination, which Slam and Lynk Global Holdings, Inc. (“Topco”), a holding company formed to complete the Business Combination, will file with the SEC.

Lakeshore Acquisition II Corp. Announces Effectiveness of Registration Statement and Date for General Meeting to Approve Proposed Business Combination with Nature’s Miracle

Retrieved on: 
Friday, February 2, 2024

NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Lakeshore Acquisition II Corp. (NASDAQ: LBBB) (“Lakeshore”), a publicly traded special purpose acquisition company, today announced that the registration statement on Form S-4 (the “Registration Statement”) in connection with its previously announced proposed business combination (the “Business Combination”) with Nature’s Miracle, Inc. (“Nature’s Miracle”), a leader in the controlled environment agriculture industry, has been declared effective by the U.S. Securities and Exchange Commission (“SEC”). The Registration Statement provides important information about Lakeshore, Nature’s Miracle and the Business Combination.

Key Points: 
  • The Registration Statement provides important information about Lakeshore, Nature’s Miracle and the Business Combination.
  • Lakeshore also announces that its extraordinary general meeting (the “Meeting”) to consider and vote upon the Business Combination and related matters has been set for February 15, 2024 at 10:00 a.m.
  • Shareholders of record as of January 10, 2024 (the “Record Date”) are eligible to attend and vote at the Meeting which will be accessible by visiting https://www.cstproxy.com/lakeshoreacquisitionii/2024 .
  • The closing of the Business Combination is subject to approval by Lakeshore’ shareholders, and the satisfaction of other customary closing conditions.

Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio

Retrieved on: 
Thursday, February 1, 2024

New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the “Business Combination”) with Tevogen Bio Inc, a Delaware corporation (“Tevogen Bio”), at an extraordinary general meeting of Semper Paratus’ shareholders that was held on Wednesday, January 31, 2024 (the “Meeting”).

Key Points: 
  • New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the “Business Combination”) with Tevogen Bio Inc, a Delaware corporation (“Tevogen Bio”), at an extraordinary general meeting of Semper Paratus’ shareholders that was held on Wednesday, January 31, 2024 (the “Meeting”).
  • Following the closing of the Business Combination, common stock of the combined company is expected to begin trading on Nasdaq under the symbol “TVGN”.
  • In connection with the Meeting, shareholders holding 1,432,457 shares out of a possible 1,502,180 Semper Paratus ordinary shares (the “Public Shares”) exercised their right to redeem their shares for a pro rata portion of the funds in Semper Paratus’ trust account (the “Trust Account”).
  • Following the Meeting, Semper Paratus’ Chief Executive Officer Surendra Ajjarapu stated “We have cleared yet another hurdle to closing our business combination with Tevogen Bio, and we will continue to work diligently with Tevogen Bio to satisfy the remaining closing conditions.”

TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP. CLOSE BUSINESS COMBINATION; TRUGOLF BECOMES PUBLICLY TRADED COMPANY

Retrieved on: 
Wednesday, January 31, 2024

SALT LAKE CITY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TruGolf, Inc. (Nasdaq: TRUG) ("TruGolf”), among the leading sellers and distributors of golf simulator software and hardware with headquarters in Salt Lake City, Utah, and Deep Medicine Acquisition Corp. (“DMAQ”), a publicly traded special purpose acquisition company, today announced that their previously announced business combination (the “Business Combination”) has closed, resulting in TruGolf becoming a publicly-traded company.

Key Points: 
  • SALT LAKE CITY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TruGolf, Inc. (Nasdaq: TRUG) ("TruGolf”), among the leading sellers and distributors of golf simulator software and hardware with headquarters in Salt Lake City, Utah, and Deep Medicine Acquisition Corp. (“DMAQ”), a publicly traded special purpose acquisition company, today announced that their previously announced business combination (the “Business Combination”) has closed, resulting in TruGolf becoming a publicly-traded company.
  • In connection with the consummation of the business combination, the combined public company was renamed “TruGolf Holdings, Inc.”
    The Business Combination and all other proposals presented were approved at an extraordinary general meeting of DMAQ stockholders held on January 19, 2024.
  • Chris Jones, CEO and Co-Founder of TruGolf, commented, “Today marks a significant milestone as we embark on our journey as a publicly traded company.
  • Additional information regarding TruGolf and the closing of the Business Combination, will be included in a current report on Form 8-K to be filed with the Securities and Exchange Commission.

Cheche Group Reports Third Quarter 2023 Unaudited Financial Results

Retrieved on: 
Wednesday, January 31, 2024

BEIJING, Jan. 31, 2024 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche", "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the third quarter ended September 30, 2023.

Key Points: 
  • BEIJING, Jan. 31, 2024 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche", "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the third quarter ended September 30, 2023.
  • For further information on the non-GAAP financial measures presented above, see the section "Use of Non-GAAP Financial Measures" below.
  • Cheche started to collaborate with NEV manufactures in 2022 and such collaboration yielded considerable results in 2023.
  • Cheche is updating its 2023 financial outlook based on improved visibility and financial results to date:
    Total written premiums placed for the full year of 2023 are expected to be between RMB21.0 billion and RMB22.0 billion, up from the previously announced RMB20.8 billion (US$3.0 billion).

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Retrieved on: 
Monday, January 29, 2024

Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) and Visiox Pharmaceuticals, Inc. (“Visiox”), a commercial-stage biopharmaceutical company, today announced that PowerUp has filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 in connection with the previously announced proposed business combination between PowerUp and Visiox (the “Business Combination” or the “Transaction”).

Key Points: 
  • Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”) (Nasdaq: PWUP) and Visiox Pharmaceuticals, Inc. (“Visiox”), a commercial-stage biopharmaceutical company, today announced that PowerUp has filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4 in connection with the previously announced proposed business combination between PowerUp and Visiox (the “Business Combination” or the “Transaction”).
  • The closing of the proposed Business Combination is subject to, among other things, approval by PowerUp’s shareholders, satisfaction of the conditions stated in the definitive agreement, and other customary closing conditions, including a registration statement being declared effective by the SEC and approval by The Nasdaq Stock Market LLC to list the securities of the combined company, which will be named Visiox Holdings, Inc. (“Visiox Holdings”).
  • Upon closing of the Transaction, Visiox will be a wholly-owned subsidiary of Visiox Holdings.
  • Visiox Holdings’ common stock and warrants are expected to be listed on Nasdaq, under the symbols “VSXP” and “VSXPW,” respectively.